Capital Advisors Ltd’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Capital Advisors Ltd’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Hold	1,219	–	–	﹤0.01%	922
2026 Q1	$4K	Buy	1,219 +1,216	+40,533%	+$3.73K	﹤0.01%	1017
2025 Q4	$0	Sell	3 -1,216	-100%	-$4.51K	﹤0.01%	1572
2025 Q3	$4K	Hold	1,219	–	–	﹤0.01%	976
2025 Q2	$2K	Hold	1,219	–	–	﹤0.01%	1103
2025 Q1	$1K	Hold	1,219	–	–	﹤0.01%	1273
2024 Q4	$0	Buy	+1,219	New	+$316	﹤0.01%	1578

Other funds holding STLN

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

T3 Companies New York $93.7M AUM

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

IAAG

Innovative Asset Advisors Group Shelton, Connecticut $229M AUM

Capital Advisors Ltd's STLN Position: Q2 2026 in Review

Capital Advisors Ltd held its Starling Oncology Institute, Inc. Common Stock (STLN) position steady in Q2 2026 at 1,219 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Capital Advisors Ltd first reported a position in STLN in Q4 2024 and has held it in 7 quarters since. 29 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

Capital Advisors Ltd held 1,219 shares of Starling Oncology Institute, Inc. Common Stock worth $7K as of Q2 2026.
Capital Advisors Ltd left its Starling Oncology Institute, Inc. Common Stock share count unchanged in Q2 2026.
Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #922 holding.
Capital Advisors Ltd first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2024 and has held it in 7 quarters since.
29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.